6 months, 1 week ago

The FDA approves a new type of schizophrenia drug

The FDA approves a new type of schizophrenia drug The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. AILSA CHANG, HOST: Today, the Food and Drug Administration approved the first new type of drug for schizophrenia in decades. LUPKIN: Since the first antipsychotic drug was introduced in the 1950s, the subsequent medications to treat psychosis act on the same chemical that helps the brain communicate with the rest of the body - dopamine. But for the first time, there's a new medicine for psychosis that does not act on dopamine and has had fewer side effects in clinical trials.

NPR

Discover Related